Enobosarm
依诺勃沙
Report date: 2026/04/23 20:00:25
NME
Base Information
Drug NameEnobosarm
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Tennessee
China Registration ClassN/A
Develop Information
Active CompaniesMerck & CoVeru IncNational Cancer Institute
Inactive CompaniesGtx Inc
Active Indications +[6]
Inactive Indications +[5]